Company / Cash per Share
Acadia Pharmaceuticals Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.07
FY2025
5-year range
$0.71 / $1.94
FY2021-FY2025
Trend
-45.1%
vs FY2024
Sector context
#145 of 205
Health Care
What the data says
At $1.07, Acadia Pharmaceuticals's cash per share ranks #145 of 205 in the Health Care sector. Cash per Share has fluctuated over the past 10 years, ranging from $0.57 in FY2017 to $2.10 in FY2020.
Based on SEC 10-K filings.
1.07 in FY2025 with a 5-year CAGR of -12.7%.
Declined from $1.16 to $1.07 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +14.3%
- 5-Year CAGR
- -12.7%
- 10-Year CAGR
- -
Sector benchmark
#145 of 205 in Health CareTop 71% of 205This company $1.07 Sector average $67.98
▼
-98.4% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 45.1% year-over-year.
- Ranks #145 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2020.
- Lowest cash per share in the period was in FY2017.
Company context
Key Data Points
- Strong profit margin: 24.9%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 28.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.07 | -45.1% |
| FY2024 | $1.94 | +66.7% |
| FY2023 | $1.16 | +63.2% |
| FY2022 | $0.71 | -22.8% |
| FY2021 | $0.92 | -56.0% |
| FY2020 | $2.10 | +59.2% |
| FY2019 | $1.32 | +21.7% |
| FY2018 | $1.08 | +89.4% |
| FY2017 | $0.57 | -64.4% |
| FY2016 | $1.61 | +57.2% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026